687 related articles for article (PubMed ID: 29417136)
1. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
[TBL] [Abstract][Full Text] [Related]
4. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
5. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
[TBL] [Abstract][Full Text] [Related]
7. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
8. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
[TBL] [Abstract][Full Text] [Related]
9. Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa.
Ovadja ZN; Schuit MM; van der Horst CMAM; Lapid O
Br J Dermatol; 2019 Aug; 181(2):344-349. PubMed ID: 30585304
[TBL] [Abstract][Full Text] [Related]
10. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
Kimball AB; Ganguli A; Fleischer A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
[TBL] [Abstract][Full Text] [Related]
11. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Hidradenitis Suppurativa Self-Assessment Tool.
Senthilnathan A; Kolli SS; Cardwell LA; Richardson I; Feldman SR; Pichardo RO
J Cutan Med Surg; 2019; 23(4):388-390. PubMed ID: 30897946
[TBL] [Abstract][Full Text] [Related]
13. The Refined Hurley Patient Questionnaire: An Accurate Self-assessment Instrument for Deriving the Correct Refined Hurley Stage in Hidradenitis Suppurativa.
Rondags A; Volkering RJ; Turcan I; Zuidema YS; Janse IC; Horvath B
Acta Derm Venereol; 2019 Jun; 99(7):703-704. PubMed ID: 30673114
[No Abstract] [Full Text] [Related]
14. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
Hayama K; Fujita H; Hashimoto T; Terui T;
J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
[TBL] [Abstract][Full Text] [Related]
15. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting quality of life in patients with hidradenitis suppurativa.
Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional Trials.
Garg A; Zema C; Ciaravino V; Rolleri R; Peterson L; Garcia L; Massaro T; Jemec GBE; Kirby JS; Thorlacius L; Ingram JR
JAMA Dermatol; 2023 Jun; 159(6):606-612. PubMed ID: 37099284
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
20. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
